Target intelligence / Profile preview

Auto-reactive T-cell

Molecular classification
T lymphocyte, CD4+ T-cell, CD8+ T-cell
01

Overview

Auto-reactive T-cells are a subset of T lymphocytes that recognize and can respond to self-antigens—components of the body’s own tissues. While most self-reactive T cells are eliminated during development in the thymus (central tolerance), some escape this process and enter the peripheral immune system. These cells have the potential to contribute to autoimmune diseases if not properly regulated. In normal physiology, they may help enhance B-cell responses when antigen-specific helper T-cell activity is limited, thus supporting antibody production. They can also be involved in regulatory mechanisms that downregulate excessive immune responses, including those against self-antigens. If peripheral tolerance fails or is overwhelmed, harmful auto-reactive T-cells can become activated and drive autoimmune pathology by attacking healthy tissues. Such activation often requires additional signals from co-stimulatory molecules or inflammatory cytokines; dysregulation at this level increases risk for autoimmune disease. Regulatory T-cells (Tregs) play a crucial role in suppressing potentially harmful auto-reactive clones through direct cell contact and secretion of anti-inflammatory cytokines.

Other names
Self-reactive T-cell
02

Biological functions

Immune responseRegulation of immune responseB cell activationT cell activationCytokine productionSelf-tolerance
03

Disease associations

Autoimmune diseaseType I diabetes mellitusMultiple sclerosisSystemic lupus erythematosusInflammation
04

Safety considerations

Potential for off-target effects when modulating T-cell activityRisk of immunosuppression

Beyond the preview

Go deeper on Auto-reactive T-cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Auto-reactive T-cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call